317 related articles for article (PubMed ID: 10373063)
1. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
LeBlanc R; Roy J; Demers C; Vu L; Cantin G
Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
[TBL] [Abstract][Full Text] [Related]
2. Effects of rhG-CSF plus dexamethasone on hemostatic parameters in healthy granulocyte donors: role of u-PA and nitric oxide.
Ekmekçi OB; Oztürk G; Ekmekçi H; Atay D; Yanaşik M; Anak S; Devecioğlu O
Clin Appl Thromb Hemost; 2009 Dec; 15(6):689-94. PubMed ID: 18544592
[TBL] [Abstract][Full Text] [Related]
3. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.
Topcuoglu P; Arat M; Dalva K; Ozcan M
Bone Marrow Transplant; 2004 Jan; 33(2):171-6. PubMed ID: 14647251
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
5. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors.
Canales MA; Arrieta R; Gomez-Rioja R; Diez J; Jimenez-Yuste V; Hernandez-Navarro F
J Hematother Stem Cell Res; 2002 Aug; 11(4):675-81. PubMed ID: 12201956
[TBL] [Abstract][Full Text] [Related]
6. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
[TBL] [Abstract][Full Text] [Related]
9. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
11. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
12. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
Ordemann R; Hölig K; Wagner K; Rautenberg U; Bornhäuser M; Kroschinsky F; Schäfer J; Schuler U; Ehninger G
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S25-8. PubMed ID: 9712488
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
[TBL] [Abstract][Full Text] [Related]
15. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
Ozcan M; Ustün C; Akçağlayan E; Akan H; Arslan O; Ilhan O; Beksaç M; Gürman G; Demirer T; Arat M; Celebi H; Konuk N; Uysal A; Koç H
Bone Marrow Transplant; 2001 Mar; 27(5):499-505. PubMed ID: 11313683
[TBL] [Abstract][Full Text] [Related]
17. Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans.
Spiel AO; Siller-Matula J; Firbas C; Leitner JM; Russmueller G; Jilma B
Platelets; 2010; 21(6):464-9. PubMed ID: 20528259
[TBL] [Abstract][Full Text] [Related]
18. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
Karadogan C; Karadogan I; Bilgin AU; Undar L
Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
[TBL] [Abstract][Full Text] [Related]
19. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
[TBL] [Abstract][Full Text] [Related]
20. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
